Skip to search
Skip to main content
Back to Search
Start Over
Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment
Authors :
Infection & Immunity MS MDL 1 Biemans, Vince B C van der Woude, C Janneke Dijkstra, Gerard van der Meulen-de Jong, Andrea E Löwenberg, Mark de Boer, Nanne K Oldenburg, Bas Srivastava, Nidhi Jansen, Jeroen M Bodelier, Alexander G L West, Rachel L de Vries, Annemarie C Haans, Jeoffrey J L de Jong, Dirk Hoentjen, Frank Pierik, Marieke J Dutch Initiative on Crohn and Colitis (ICC) Infection & Immunity MS MDL 1 Biemans, Vince B C van der Woude, C Janneke Dijkstra, Gerard van der Meulen-de Jong, Andrea E Löwenberg, Mark de Boer, Nanne K Oldenburg, Bas Srivastava, Nidhi Jansen, Jeroen M Bodelier, Alexander G L West, Rachel L de Vries, Annemarie C Haans, Jeoffrey J L de Jong, Dirk Hoentjen, Frank Pierik, Marieke J Dutch Initiative on Crohn and Colitis (ICC)
Publication Year :
2020
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1432112973
Document Type :
Electronic Resource